Pre-seed · Healthtech
Gabify raises $175,000 pre-seed led by Inflection Point Ventures
The company plans clinical validation, product development and hiring for its neurodevelopmental tools.
Gabify announced $175,000 in pre-seed financing on April 2, 2026, led by Inflection Point Ventures. The company planned to invest in clinical validation, technology and team expansion.
The capital supports development of a platform that combines voice and visual analysis with professional oversight for early screening. Gabify was also developing distribution through schools, healthcare providers, families and corporate social-responsibility programmes.
Use of funds
Clinical validation
Product development
Team expansion
Funding history
Pre-seed · This round$175K